Log In | Register
GlaxoSmithKline said last week that it expects to take a $2.36 billion charge against second-quarter earnings for settlements, agreements to settle and other provisions for long-standing legal cases over Paxil
Settlement in Paxil Birth Defects lawsuit
Seeded on Wed Jul 21, 2010 2:38 PM EDT
Article Source: Google- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
According to the lawsuit, Nathan Berg was born Aug. 20, 2004 at Watertown and was immediately transferred to a Minneapolis hospital where he died 58 days later of Persistent Pulmonary Hypertension of the Newborn (PPHN), a disorder which prevents proper oxygenation of the blood.
"At the time Paxil was prescribed to Ms. Berg, GSK (GlaxoSmithKline) knew or should have known through pre-market studies and post-market studies and reports that Paxil was associated with an increased risk of PPHN in babies whose mothers ingested Paxil during pregnancy," according to the lawsuit.
I think it might be good for the industry to have GSK's developmental research released to the public.
Lets have some slides & samples SHOWING NO EFFECTS on fetal development.
#YEAHthat'llhappen'
#1 - Wed Jul 21, 2010 3:08 PM EDTYou're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
